LEO JOHN SEMAN,LEO THOMAS,MICHAEL MARK,Peter Eickelmann,ROLF GREMPLER,ULI BROEDL
申请号：
BRPI1013640
公开号：
BRPI1013640A2
申请日:
2010.02.11
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
